ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC

Company to host a conference call and webcast on Tuesday, March 31, 2026 at 4:30 pm ET Company to host a conference call and webcast on Tuesday, March 31, 2026 at 4:30 pm ET